Patents Assigned to Oxford University
-
Patent number: 10948397Abstract: Characteristics of polarizable particles in a fluid are detected using an optical cavity comprising opposed optical reflectors containing the fluid. A particle is introduced through the fluid into the optical cavity. The particle may be transiently in the cavity or optically trapped. The optical cavity containing the particle is illuminated with light that excites resonance of an optical mode of the optical cavity that is affected by the particle. A measurement of a parameter of the excited resonance is derived, for example while tuning through the resonance. Repeated measurements may be used to derive a measure of a characteristic of the particle that is dependent on the motion of the particle in the optical cavity.Type: GrantFiled: May 22, 2017Date of Patent: March 16, 2021Assignee: Oxford University Innovation LimitedInventors: Aurélien Trichet, Jason Michael Smith, Claire Vallance
-
Patent number: 10950376Abstract: The invention relates to a process for moving a droplet from a first location to a second location, which droplet comprises a magnetic material disposed in an aqueous medium. The invention also relates to a droplet assembly comprising a droplet, which droplet comprises a magnetic material disposed in an aqueous medium. Various uses of the droplet assembly are also described.Type: GrantFiled: October 25, 2013Date of Patent: March 16, 2021Assignee: Oxford University Innovation LimitedInventors: John Hagan Pryce Bayley, Kunwar Tanuj Sapra, Tobias Wauer, Holger Gerlach, Shiksha Mantri, Jamie Hill
-
Patent number: 10939852Abstract: A method of monitoring changes in oxygen saturation of a subject by analysing a three colour channel video image of the exposed skin of the subject. Within each colour channel a normalised signal obtained by dividing the intensity signal by its mean value, and the normalised signals are averaged across plural regions of interest within the exposed skin area image of the subject. Regions of interest are selected on the basis of the signal-to-noise ratios for the heart rate and breathing rate components. A single representative waveform for each colour channel is obtained by signal averaging and the ratio of the amplitudes of the representative waveforms from two different colour channels, e.g. blue and red, is taken. The changes in the ratio of amplitudes is output as a measure of changes in blood oxygen saturation.Type: GrantFiled: June 2, 2016Date of Patent: March 9, 2021Assignee: OXFORD UNIVERSITY INNOVATION LIMITEDInventors: Alessandro Guazzi, Mauricio Villarroel Montoya, Lionel Tarassenko
-
Patent number: 10934635Abstract: There is provided a method of fabricating a trapped vacancy in a crystal lattice of a target comprising: positioning the target in a laser system, the target containing vacancy trapping elements within the crystal lattice; modifying the crystal lattice within the target by using a laser to generate a lattice vacancy; and annealing the target to cause the lattice vacancy to migrate and be captured by a vacancy trapping element to form the trapped vacancy in the crystal lattice.Type: GrantFiled: July 1, 2016Date of Patent: March 2, 2021Assignee: Oxford University Innovation LimitedInventors: Martin James Booth, Patrick Salter, Jason Smith, Yu-Chen Chen
-
Patent number: 10934578Abstract: The present invention relates to a method of identifying nucleic acid regions within a nucleic acid sample which interact with one another. In particular, the method relates to a chromatin conformation capture (3C) method which may be used to analyse the interactions between enhancers, silencers, boundary elements and promoters at individual loci at high resolution.Type: GrantFiled: October 24, 2016Date of Patent: March 2, 2021Assignee: Oxford University Innovation LimitedInventors: James R. Hughes, James Davies
-
Patent number: 10927013Abstract: The present invention relates to a semiconductor device comprising a semiconducting material, wherein the semiconducting material comprises a compound comprising: (i) one or more first monocations [A]; (ii) one or more second monocations [BI]; (iii) one or more trications [BIII]; and (iv) one or more halide anions [X]. The invention also relates to a process for producing a semiconductor device comprising said semiconducting material. Also described is a compound comprising: (i) one or more first monocations [A]; (ii) one or more second monocations [BI] selected from Cu+, Ag+ and Au+; (iii) one or more trications [BIII]; and (iv) one or more halide anions [X].Type: GrantFiled: August 31, 2016Date of Patent: February 23, 2021Assignee: OXFORD UNIVERSITY INNOVATION LIMITEDInventors: Henry James Snaith, Amir Abbas Hagighirad, Feliciano Giustino, Marina Filip, George Volonakis
-
Patent number: 10928478Abstract: Described herein are methods for monitoring and/or extracting subject motion from multi-channel electrical coupling in imaging of the subject, in particular in magnetic resonance (MR) imaging of the subject.Type: GrantFiled: May 28, 2019Date of Patent: February 23, 2021Assignee: OXFORD UNIVERSITY INNOVATION LIMITEDInventors: Aaron Hess, Matthew Robson, Sven Jaeschke
-
Patent number: 10928350Abstract: Herein is disclosed a method for detecting a material comprising a thiol group (e.g. homocysteine, cysteine, glutathione) in a sample, the method comprising: •providing an electrode comprising a carbon material; •contacting said electrode with said sample in the presence of catechol or more generally a precursor of ortho-quinone; •performing cyclic or square wave voltammetry to convert catechol to ortho-quinone and wherein said ortho-quinone reacts with the material comprising a thiol group to form an electrochemical reaction product.Type: GrantFiled: March 20, 2015Date of Patent: February 23, 2021Assignee: OXFORD UNIVERSITY INNOVATION LIMITEDInventors: Patricia Tung Lee, Denise Lowinsohn, Richard Guy Compton
-
Patent number: 10931252Abstract: A re-configurable magnetoinductive waveguide (300), comprising a plurality of resonator cells, wherein each resonator cell comprises a primary resonator (110) that is inductively coupled to a primary resonator (110) of at least one other resonator cell, and wherein at least one of the plurality of resonator cells is a controllable cell (100) which further comprises a control element (120), the control element (120) having an active control component (125) that is operable to adjust the impedance of the primary resonator (110) of the controllable cell (100) in response to a control signal; wherein: the control element (120) comprises a secondary resonator, the secondary resonator is inductively coupled to the primary resonator (110), and the active control component (125) is arranged to vary the electrical properties of the secondary resonator in response to the control signal.Type: GrantFiled: March 17, 2017Date of Patent: February 23, 2021Assignee: Oxford University Innovation Ltd.Inventors: Christopher Stevens, Ekaterina Shamonina, Jan Paszkiewicz
-
Patent number: 10914681Abstract: A functional material includes a porous metal-organic framework (MOF) including an organic ligand derived from benzenedicarboxylic acid and a metal ion cluster coordination-bonded with the organic ligand, and a luminescent molecule in pores of the MOF.Type: GrantFiled: July 21, 2017Date of Patent: February 9, 2021Assignees: Samsung Electronics Co., Ltd., OXFORD UNIVERSITY INNOVATION LIMITEDInventors: Ha Jin Kim, In Taek Han, Abhijeet K. Chaudhari, Jin-Chong Tan
-
Patent number: 10910859Abstract: A smart cell, comprising: a positive terminal; a negative terminal; a switching circuit which is arranged to select between a first switching state in which an energy storage device is connected between the positive terminal and the negative terminal and a second switching state in which bypasses said energy storage device; and an inductor provided between the positive terminal and the negative terminal. The inductor provides a means by which to monitor current changes in the rest of the circuit. The inductor can thus be used to detect current changes as seen by the smart cell and this sensed information can be used to control the smart cell, e.g. to control an energy source (energy storage device) that forms part of the smart cell. As the inductor is part of the smart cell, it forms part of a decentralized controller strategy to regulate the state of charge of cells within a larger system.Type: GrantFiled: August 12, 2016Date of Patent: February 2, 2021Assignee: OXFORD UNIVERSITY INNOVATION LTDInventors: Damien Frost, David Howey
-
Patent number: 10900081Abstract: The present invention is concerned with prenatal screening and in particular non-invasive prenatal screening, as well as primers, primer sets and kits. In one instance, the invention provides a method of prenatal screening comprising: (a) amplifying a region encompassing the site of a mutation site responsible for the disorder, the amplification being performed on a DNA sample obtained from a pregnant female which comprises both maternal and fetal DNA; (b) sequencing a plurality of products from the amplification and determining whether or not the mutant allele is represented at a different frequency to that expected from the genotype of the pregnant female alone.Type: GrantFiled: March 14, 2014Date of Patent: January 26, 2021Assignee: Oxford University Innovation LimitedInventors: Anna Schuh, Shirley Jane Henderson
-
Patent number: 10889507Abstract: A process for producing a metal oxide powder comprising: providing a precursor solution or dispersion containing a metal complex; spraying the precursor solution on to a heated substrate in the presence of water, thereby depositing material on the substrate; drying the deposited material; and removing the deposited material from the substrate to produce the metal oxide powder.Type: GrantFiled: February 6, 2017Date of Patent: January 12, 2021Assignee: OXFORD UNIVERSITY INNOVATION LIMITEDInventors: Peter Edwards, Jonathan Dilworth, Vladimir Kuznetsov, Catherine Hayes
-
Patent number: 10889622Abstract: The present invention relates to a polypeptide that is capable of promoting the covalent conjugation of two peptide tags or linkers and in particular to a polypeptide comprising: a) an amino acid sequence as set forth in SEQ ID NO: 1; or b) an amino acid sequence with at least 80% sequence identity to a sequence as set forth in SEQ ID NO: 1, wherein said amino acid sequence comprises a glutamic acid at position 61 and one or more of the following: 1) proline at position 66; 2) proline at position 95; 3) glycine at position 96; and 4) valine at position 97, wherein the specified amino acid residues are at positions equivalent to the positions in SEQ ID NO: 1 and wherein said polypeptide is capable of promoting the formation of an isopeptide bond between the lysine residue at position 9 of SEQ ID NO: 2 and the asparagine residue at position 17 of SEQ ID NO: 3.Type: GrantFiled: April 10, 2018Date of Patent: January 12, 2021Assignee: Oxford University Innovation LimitedInventors: Mark Howarth, Can M. Buldun
-
Patent number: 10888854Abstract: Catalytic compositions comprising permethylpentalene based metallocene complexes supported on solid methylaluminoxane are disclosed. The compositions are effective catalysts/initiators in the polymerisation of olefins. Also disclosed are uses of the compositions in olefin polymerisation.Type: GrantFiled: October 4, 2016Date of Patent: January 12, 2021Assignee: Oxford University Innovation LimitedInventors: Dermot O'Hare, Jean-Charles Buffet, Zoe Turner, Duncan Fraser
-
Publication number: 20210000803Abstract: The invention relates to the treatment or control of unipolar depressive disorder by administering a compound of Formula I or a salt thereof to a subject; wherein: E is S or Se; R1 and R2 are optional substituents, and are at each occurrence independently selected from: (1) a halogen, which is preferably selected from F, Cl and Br; (2) C1-C4 alkyl, such as C1-C2 alkyl or C1 alkyl, optionally substituted with one or more halogen atoms, each of which is preferably selected from F, Cl and Br; and (3) C1-C4 alkoxy, such as C1-C2 alkoxy or C1 alkoxy; optionally substituted with one or more halogen atoms, each of which is preferably selected from F, Cl and Br; m is an integer in the range of from 0 to 5; and n is an integer in the range of from 0 to 4.Type: ApplicationFiled: October 26, 2018Publication date: January 7, 2021Applicant: OXFORD UNIVERSITY INNOVATION LIMITEDInventors: Trevor SHARP, Philip COWEN, Grant CHURCHILL
-
Publication number: 20210000934Abstract: The invention relates to an adjuvant comprising Pattern Recognition Receptor (PRR) agonist molecules linked to polymer chains that are capable of undergoing particle formation in aqueous conditions, or in aqueous conditions in response to external stimuli; and methods of treatment or prevention of disease using such an adjuvant.Type: ApplicationFiled: June 22, 2020Publication date: January 7, 2021Applicants: Oxford University Innovation Limited, The U.S.A., as Represented by the Secretary, Department of Health and Human ServicesInventors: Kerry Fisher, Richard Laga, Geoffrey Lynn, Leonard Seymour, Robert Seder
-
Patent number: 10884090Abstract: The present invention relates to methods of assessing or obtaining an indication of the presence of a cognitive disorder by analysing microstructural changes in regions of the brain. The invention particularly relates to methods of assessing or obtaining an indication of the presence of types of dementia, for example Alzheimer's disease, by analysing changes in minicolumns in regions or layers of the cortex of the brain or of the whole brain.Type: GrantFiled: April 7, 2016Date of Patent: January 5, 2021Assignee: Oxford University Innovation LimitedInventors: Steven Chance, Rebecca McKavanagh, Mark Jenkinson, Karla Miller
-
Publication number: 20200407785Abstract: The invention relates to a method for sequencing a heteropolymeric target nucleic acid sequence that involves stochastic sensing. The invention also relates to a method for improving a pore for sequencing a target nucleic acid sequence by modifying one or more sites in the pore.Type: ApplicationFiled: April 27, 2020Publication date: December 31, 2020Applicant: Oxford University Innovation LimitedInventors: David Jackson Stoddart, Andrew John Heron, Giovanni Maglia, John Hagan Pryce Bayley
-
Patent number: 10877033Abstract: The invention relates to methods of detecting the presence or absence of autoantibodies in an individual and to related methods and kits. In particular, the disclosure concerns measuring from one or more samples from an individual suspected of having a disease with an autoimmune component for binding of one or more autoantibodies to membrane vesicles comprising corresponding one or more antigens.Type: GrantFiled: June 18, 2014Date of Patent: December 29, 2020Assignee: Oxford University Innovation LimitedInventors: Angela Vincent, Patrick Joseph Waters, Alexandru Radu Aricescu